A phone call guided visual acuity self assessment in AMD patients - prognostic value of standardized tests and comparison of recent usual care versus phone call-based screening strategy for maintaining the vision gain after Ranibizumab injections

A phone call guided visual acuity self assessment in AMD patients - prognostic value of standardized tests and comparison of recent usual care versus phone call-based screening strategy for maintaining the vision gain after Ranibizumab injections - AMD phone study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00000768

Enrollment

Registered

2011-05-18

Start date

2011-09-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

age-related macular degeneration H35.3

Interventions

Group 1: Intervention Group: Phone screening procedures in advance of monthly clinic examinations over 6 months

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. wet age-related macular degeneration, pretreated or untreated, 2. Visual acuity 69-24 ETDRS-letters at least one eye 3. Age> 60 years 4. written consent for study participation of the patient 5. Upload indication for treatment (3 injections with ranibizumab) or for maintenance therapy in previously treated patients with Ranibizumab 6. Patient has a technical (telephone) and other conditions for carrying out the study procedures 7. regular visits at the clinic is possible

Exclusion criteria

Exclusion criteria: 1. Patients with active ocular or periocular infection or suspected to 2. Patients with severe intraocular inflammation 3. previous photodynamic therapy 4. uncontrolled glaucoma, uveitis, advanced cataract 5. State after filtration surgery, status post retinal surgery, status post intraocular surgery in less than 3 months 6. known allergy to ranibizumab 7. physically, mentally or otherwise induced inability to provide information requested (eg questionnaire: because of dementia, language difficulties, ...) or to participate in the tests required 8. Participation in other interventional therapy studies 9. lack of cooperation (compliance) 10. not permitted concomitant therapies

Design outcomes

Primary

Measure	Time frame
Reliability and validity of telephone-assisted visual acuity self-test of patient by ACTO and Amsler procedures compared to clinical diagnosis cascade (ETDRS, funduscopy, OCT, possibly photography of the fundus and FAG)	—

Secondary

Measure	Time frame
further aspects of reliability of the telephone screening: • test-retest reliability; • inter-rater reliability; acquisition of the quality of life for vision by NEI (patient self-report) questionnaires	—

Countries

Germany

Contacts

Public ContactPeter Wiedemann

Universitätsklinikum Leipzig AöR Klinik und Poliklinik für Augenheilkunde,

peter.Wiedemann@medizin.uni-leipzig.de0341 – 97 21 650

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026